The intestinal microflora can be considered as a postnatally aquired organ composed of a large diversity of bacterial cells that can perform different functions for the host. This organ is highly exposed to environmental influences and thus modulated in its composition and functions by external factors, such as nutrition. Specific components of the intestinal microflora, including lactobacilli and bifidobacteria, have been associated with beneficial effects on the host, such as promotion of gut maturation and integrity, antagonisms against pathogens and immune modulation. In addition, the microflora seem to play a significant role in the maintenance of intestinal immune homeostasis and prevention of inflammation. At the present time, the contribution of intestinal epithlial cell in the first line of defence against pathogenic bacteria and microbial antigens has been recognized, in contrast, the interactions of intestinal epithelial cells with commensal bacteria are less understood. The present work summarizes the increasing scientific attention for mechanisms of the innate immune response of the host to different components of the autochthonous microflora and suggests a potential role for selected probiotic bacteria in the regulation of intestinal inflammation.
Introduction
Humans live in a bacterial world, and microbes from the environment are in permanent contact with the skin and the mucosal surfaces of the body that can remain sterile (distal respiratory tract), or become colonized (gastrointestinal (GI) tract). There are more bacterial cells in the indigenous microbiota of the gut than the body's own eucaryotic cells (Blaser & Musser, 2001) .
The intestinal microbiota involves a wide diversity of bacterial species. It is in permanent interaction with environmental microorganisms but maintains a remarkable stability in composition. There are different bacterial habitats along the GI tract. The mechanisms of control that maintain the equilibrium of the microbiota at different levels of the intestine are unknown. The composition of the gut microbiota may transiently vary as a consequence of an important bacterial inoculum in the diet (Bouhnik et al, 1992) or due to ingestion of colonic foods (Bouhnik et al, 1999) . Changes of the microbiota are also observed in pathological conditions such as enteral infections, antibiotherapy, anti-acid treatment and immune suppression.
Immediately after birth the sterile intestine of the fetus is colonized by environmental microbes. The type of neonatal feeding may influence the composition of the microflora as shown by the differences found between the intestinal microflora of breast-fed and formula-fed babies (Benno et al, 1984) . In the elderly, a reduction in bifidobacteria, has been reported (Hopkins et al, 2001 ) among other modifications of the microbiota.
Commensal colonization of the gut affects nutritional and defensive functions of the intestine by modulating gene expression (Hooper et al, 2001 ). Different bacteria may induce different gene activation. Thus the manipulation of the host microflora may represent a new possibility in the prevention or management of GI pathophysiological disorders.
Mucosal surfaces are exposed to commensal and pathogenic microbes. Although the real magnitude of the host exposure to pathogens is difficult to assess, it appears that these encounters rarely result in infectious diseases. Mucosal mechanisms of defense are responsible for protection, however the control of inflammatory reactivity is an important condition in preserving the integrity of the mucosal interface with the external world.
Stability of the intestinal microbiota composition
Host and microbial factors are probably implicated in the establishment and composition of the intestinal microbiota. The colonization of the intestinal mucosa by a pathogen may result in cell damage and thus initiate a host response to eliminate the noxious agent, mounting an inflammatory reaction. In contrast, commensals do not induce a strong epithelial defensive response. However they exert some type of immune-modulation on the host. The homeostasis of host functions probably requires some type of stability in the microflora composition; however very little is known about factors that may contribute to preserve the steady-state.
An immunological surveillance of intestinal bacteria seems to take place, but how the host's immune response to commensals affects intestinal colonization remains to be elucidated.
Two different control mechanisms can be distinguished: (a) bacteria -bacteria interactions (host independent); and (b) host -bacterial interactions. Examples of the first type are bacterial metabolic activities that, through the production of short chain fatty acids, O 2 consumption, or modifications of the redox potential, modify the intestinal ecology creating ecosystems that are appropriate for some bacterial genera but hostile for others. The production of antimicrobial compounds or the competition for receptors on the mucus layer or on intestinal epithelial cells are additional relevant factors in intestinal colonization. The communication among bacteria in biofilms or definite microenvironments, called quorum sensing, may also play a role in colonization.
Host -microbial interactions also seem to be of high complexity and are just starting to be characterized. Hostbacterial interactions appear to be relevant in the control of the intestinal microbiota composition. In turn, the indigenous microflora participates in the development and maturation of the gut (Hooper et al, 2001) , and the regulation of intestinal functions.
Interactions between the host and the intestinal microflora
The intestinal microbiota plays a role in the development of host's innate and adaptive immune responses (Cebra, 1999) . Some authors have proposed that the immune system does not react (is tolerant) against the commensal microflora and the breakdown of immunological tolerance to indigenous bacteria may lead to chronic inflammatory bowel disease (IBD; Duchmann et al, 1995) . However it has also been reported that commensal bacteria can elicit systemic antibody responses (Kimura et al, 1997) . In addition a proportion of the resident microflora is covered by antibodies in the lumen of the gut, mainly of the IgA isotype (Van der Waaij et al, 1996) .
Secretory or systemic antibody responses to components of the intestinal microbiota appear to have neither pathogenic consequences for the host nor does it seem to result in the elimination of bacteria from the intestine. Thus, it is unknown whether the immune response plays any role in the constitution of the commensal microbiota. What seems clear is that this immune response against commensal microflora does not lead to tissue damage. The modulatory mechanisms that prevent a deleterious inflammatoryimmune response are not totally unravelled.
Antigen-specific CD4 þ regulatory T cells were shown to be an important lymphocyte subset for the balance of protective and pathogenic immune responses. These cells produce predominantly IL-10 or TGFb upon stimulation, and promote the down regulation of the inflammatory process (Groux et al, 1997) .
Innate mechanisms of defense may also play a role in the regulation of intestinal homeostasis and contribute to the control of the inflammatory reaction at the lamina propria. Arachidonic acid metabolites generated through the cyclooxygenase-2 (COX-2) pathway seem to be essential modulators of the intestinal response to dietary antigens (Newberry et al, 1999) . COX-2 is expressed by intestinal epithelial cells (IEC) and macrophages. Enzyme activity results in the production of metabolites such as PGE2, which has immunomodulatory activities such as down regulation of MHC-class II antigens (Snyder et al, 1982) , and induction of IL-10 production (Demeure et al, 1997) .
The induction of COX-2 activity in lamina propria macrophages depends on bacterial lipopolysaccharide (LPS) stimulation. In addition, non bone marrow-derived lamina propria cells in the small bowel have the capacity to express basal levels of COX-2 in the absence of exogenous stimuli (Newberry et al, 2001) . Therefore commensal bacteria may exert a dual function, the stimulation of mucosal mechanisms of defense on one side and the maintenance of the homeostasis of the immune response on the other.
Several mechanisms may work in concert to avoid the chronic inflammatory reaction at the intestinal barrier; however chronic intestinal inflammatory disease is a frequent pathology in humans.
The development of intestinal inflammation in knockout and transgenic rodents has confirmed how genetic and environmental factors are both responsible for mucosal inflammation. Spontaneous inflammation of the GI tract has been demonstrated in transgenic rats expressing the human HLA-B27 and b2-microglobulin, in mice deficient for IL-2, IL-2Ra, IL-10, TCRa, TGF-b1 and others. In most of the murine models no inflammation occurs if animals are maintained under germ-free conditions (Bhan et al, 1999) .
The diversity of murine genetic defects that may lead to experimental IBD seems to indicate that more than one or a few specific pathogenic genes are involved in the pathogenesis; the disease may result from a lack of global immune regulation at the critical interphase of the host with the external environment.
Mucosal reaction to bacteria: from homeostatic regulation to immune-inflammatory damage
The diversity of bacterial genetic make-up to which humans are exposed at the mucosal surfaces is extremely wide. Gastric acid pH, the mucus layer, production of bactericidal peptides such as a-defensins, the integrity of the epithelial layer, are non-specific factors that give wide protection to the host.
The mucosal barrier is not only a physical obstacle for bacterial invasion of the host but also a reactive compartment with the capacity to sense environmental changes and respond to them.
These mucosal functions require a molecular machinery for microbial recognition. Bacterial recognition may either rely on a wide repertoire of specific molecules or in fewer, less specific molecules, that recognize microbial traits common to different genera and species, called pattern recognition receptors (PRR; Medzhitov & Kopp, 1999) .
Specific molecules for bacterial recognition are immunoglobulins (Ig) and T cell receptors (TCR), which are part of the adaptive immune response, and need molecular adaptation to bacterial molecules in order to successfully accomplish recognition.
On the other hand, PRRs are germ-line-encoded glycoproteins that recognize similar bacterial molecules across bacterial genera and species. In the gut, mucosa PPRs are found on lamina propria macrophages placed beneath the epithelial layer.
CD14 and the family of molecules called Toll like receptors (TLR) are examples of PRRs. CD14 was shown to react with TLR4 to deliver signals to eucaryotic cells (Zhang & Ghosh, 2001 ). Different members of TLR family react with different type of bacterial components. Thus while TLR4 participates in the recognition of Gram-negative products, ie lipopolysaccharide (LPS), TLR2 is involved in signaling immune cells upon reaction with molecules present in Gram-positive bacteria, ie lipotheichoic acid (LTA) and peptidoglycan (PG). Ten TLR molecules have been described so far in mammalians, and it is assumed that each of the TLRs recognizes a discrete subset of molecules widely shared by microbial pathogens. Thus, together, TLRs afford protection against an important number of pathogenic bacteria. Reaction of bacterial products with TLRs, results in cellular signaling, and frequently in NF-kB or AP-1 activation (Janeway et al, 1996) .
The ability to discriminate between pathogens and commensals is crucial for the intestinal mucosa. The discrimination may depend on bacterial feature recognition by PRR. It has been proposed that, in addition to sensing bacterial presence via PRR, a second danger signal may initiate an appropriate response to pathogenic bacteria (Matzinger, 1998) . Endogenous ligands of PRR, and more specifically TLRs, may initiate an immune activation upon detection of cell damage or cellular stress. These endogenous 'danger signals' may be heat shock proteins, nucleotides or extracellular matrix breakdown products. This has given origin to the so-called 'danger model' of the immune response where activation occurs only if host tissue damage is detected.
One feature of bacterial pathogenicity is the capacity to invade host epithelial cells. The defensive systems can also recognize non-invading pathogens when they induce cytopathic or enterotoxic effects, or when they target membrane cell compartments non-exposed to the lumenal environment (Philpott et al, 2001) .
The recognition of pathogens before induction of tissue damage, in the lumen of the gut, remains for the moment speculative, but some bacterial stimulation of airway and intestinal epithelia may result in the production of bactericidal proteins such as defensins. Interestingly epithelial expression of defensins seems to depend on the recognition of bacterial molecules by PRR such as CD14.
Mucosal epithelium may sense the intestinal bacterial content and the danger of infection
The epithelium of the intestinal tract is a constitutive component of the innate response of the host toward the lumenal microbiota.
It has been shown that epithelial cells can mount an innate response to invasive pathogens (Jung et al, 1995) . Intracellular LPS is detected by a protein called caspaseactivating and -recruitment domain 4 (CARD4=, also known as NOD1) and is involved the NF-kB pro-inflammatory activation (Bertin et al, 1999) .
The innate epithelial host response also seems to be able to discriminate between commensals and pathogens in the absence of invasion. The molecular bases of discrimination between commensals and pathogens may depend on different molecular mechanisms. It has been postulated that conserved bacterial molecules, present in pathogens as well as non-pathogens, promote an epithelial response when detected in combination with a second danger signal. It has been recently reported that the recognition of flagellin in the basolateral membrane of the intestinal epithelium, may initiate a defensive response, subsequent to TLR5 binding (Philpott et al, 2001) .
Furthermore, the IEC also recognizes and responds to non-pathogenic commensal bacteria (Haller et al, 2000) . It has been demonstrated in vitro that the epithelial cell response to non-pathogens was enhanced upon co-culturing IEC with peripheral blood mononuclear cells. Notably, a differential response to non-pathogenic bacteria could be observed distinguishing two major cytokine=chemokine profiles of IEC (see also Figure 1 Both types of epithelial responses against non-pathogenic bacteria seem to indicate the importance of either a selflimiting (type 1) or non-inflammatory (type 2) cellular immune response in the context of the antigen rich intestinal environment.
If bacterial invasion occurs, the inflammatory reaction persists in order to recruit leukocytes for the clearance of the pathogen. Thus, epithelial recognition and response to pathogens may require multi-step stimulation, comprising the recognition of bacteria at least at the beginning, and then cellular damage. When the pathogen has been eradicated, regulatory mechanisms intervene to stop the inflammatory response and restitute the intestinal barrier integrity. Thus, an integrated epithelial-lamina propria cell interaction may also be crucial for tissue restitution.
NF-kB activation is a pivotal event in defensive inflammatory reactions, inducing gene activation such as IL-2, IL-6, IL-8 and TNF-a (Baldwin, 2001) . Pathogens and stress are common activators of this pathway. In addition, NF-kB activation may play a pathogenic role in chronic inflammatory diseases, including arthritis and inflammatory bowel disease such as Crohn's disease. NF-kB proteins are a family of heterodimers and homodimers with different activatory capacity. The p50 and p65 heterodimers are involved in IL-1 and TNF-a gene activation and are blocked by IL-10 (Tak & Firestein, 2001) . NF-kB exists in the cytoplasm in an inactive form associated with regulatory proteins called inhibitors of kB (IkB). Phosphorylation of IkB is required for NF-kB activation. Phosphorylated IkB is ubiquitinated and degraded in the 26S proteosome. NF-kB is then released from the complex with IkB, translocated to the nucleus, where pro-inflammatory gene activation is initiated.
An association between Crohn's disease and a mutation in NOD-2 gene has been recently reported. NOD-2 encodes a cytosolic protein whose expression is restricted to monocytes (Hugot et al, 2001) . NOD-2 protein is a member of the CED4=APAF1 superfamily of apoptosis regulators. It is composed of two caspase recruitment domains (CARD), a nucleotide-binding domain, and a leucine-rich repeat (LRR) in its carboxy terminus side. The LRR domain binds lipopolysaccharide and activates the NF-kB pathway; however this induction is deficient in the mutant NOD-2. This genetic defect may be related to perdurable pathogenic inflammatory-immune response. However, the mechanisms that link the carriage of the mutated NOD-2 variant and the persistent tissue inflammation in Crohn's disease has not been unraveled yet.
NF-kB modulation has become an obvious target for antiinflammatory therapy. It has been recently reported that some non-pathogenic bacteria can prevent NF-kB activation through inhibition of IkB-a ubiquitination. This may suggest that luminal microflora can send positive and negative signals to mucosal epithelial cells as part of the interactions with the host (Neish et al, 2000) . Thus, bacterial strains, which induce immuno-regulatory cytokines at the IEC level, may modulate inflammation without the participation of lamina propria cells, such as macrophages or lymphocytes. This could represent a strategy to control inflammation in the gut when the integrated epithelia-lamina propria cell loop is impaired due to genetic defects.
The homeostatic response to a limited epithelial inflammation controlled by immunomodulatory cytokines such as TGF-b, IL-10; PGE2 or an appropriate NF-kB regulation may be impaired in IBD.
Therefore, commensal bacterial strains, including probiotic bacteria, selected for their properties to activate an epithelial inhibitory response may be a rational nutritional intervention in IBD patients.
